Skip to main content
Offering
Offering
Integrated Biologics
Integrated Biologics
Expression Technologies
Expression Technologies
GS Xceed® Gene Expression System
GS piggyBac® Transposon Technology
GS Effex® Cell Line
GS Discovery® Transient Expression
bYlok® Bispecific Pairing Technology
XS Technologies® Platform
Technical Support
Early Derisking and Optimization
Early Derisking and Optimization
Developability Assessment
Manufacturability Assessment
Immunogenicity / Immunotoxicity Assessment
Early Protein Expression Services
Integrated DNA-to-IND Programs
Integrated DNA-to-IND Programs
mAbs DNA-to-IND Program
Bispecifics DNA-to-IND Program
Fabs and Fc-Fusion Proteins DNA-to-IND Programs
Scaffolds and other Recombinant Proteins
Manufacturing
Manufacturing
Mammalian Drug Substance Manufacturing
Drug Product Manufacture
OptiALTO™ Intensified Fed-Batch Platform
Development Services
Development Services
Biologics Process Development
Biologics Analytical Development
Formulation and Primary Packaging Development
Mammalian Biopharmaceutical Services
Mammalian Biopharmaceutical Services
Cell Line Development
Tailored License Application Program
Process Development
Parenteral Drug Product Services
Parenteral Drug Product Services
Clinical Technology Transfers
Biologics Formulatability
Process Development
Biologics Special Services
Large-scale Manufacturing Expansion
Biologics Regulatory Affairs Services
Knowledge Center
Advanced Synthesis
Advanced Synthesis
Small Molecules
Small Molecules
Drug Substance/API Services
Drug Substance/API Services
Accelerate Early Drug Development with Lonza Design2Optimize®
Early Phase Small Molecule Development Services
API Support for Early Phase Development
AI-Enabled Route Scouting Service
Solid Form Drug Services
PBPK Modeling Services
High-Throughput Experimentation (HTE) | Accelerate Chemical Optimization with Lonza
Pharmaceutical Method Development
Commercial API Manufacturing Services
Highly Potent API Technologies
Highly Potent API Technologies
HPAPI Handling and Development
HPAPI Manufacturing | Low & High Potency
ADC Clinical and Commercial Manufacturing
ADC Payload Product Development
Particle Engineering
Particle Engineering
Solid Dispersion Technology
Bioavailability Enhancement
Spray-Dried Dispersion Technology
Drug Product
Drug Product
Clinical Trial Material Manufacture, Supply
Formulation and Development
Design and Preformulation Development
Drug Development Workflow & Pharmaceutical Process Optimization
Inhalation Formulation Development
Integrated Offerings
Regulatory Affairs CMC Services
Regulatory Affairs CMC Services
CMC Development Services | CMC Regulatory Submissions
Bioconjugation Services
Bioconjugation Services
Early Development Bioconjugate Services | ADCs
ADC Drug Substance Manufacturing
Pharmaceutical, ADC Analytical Services
Targeting Agent and Carrier Protein
ADC Process Development
Ibex® Design ADC, DNA-to-IND Program
ADC Technologies Platform
Knowledge Center
Specialized Modalities
Specialized Modalities
Cell & Gene
Cell & Gene
Process Development
cGMP Manufacturing
Allogeneic
Autologous
Viral Vectors
Exosomes
Microbial
Microbial
Microbial Strain Development
Process Development
Drug Substance Manufacturing
Analytical Development
mRNA/LNP
mRNA/LNP
Process Development
Analytical Services
mRNA Manufacturing
Lipid Nanoparticles Encapsulation
Bioscience Products
Knowledge Center
Knowledge Center
Company
Company
About Us
About Us
Our One Lonza Strategy
Our Leadership
Our Leadership
Executive Committee
Board of Directors
Board Committees
Our History
Our Locations
News and Media
News and Media
News Releases
Images and Videos
Logo Guidelines
Blog
A View On - Lonza Podcast
Journalist Inquiries
Investor Relations
Investor Relations
Shareholder and Bondholder Information
Shareholder and Bondholder Information
Consensus and Analysts
Bond Investors and Credit Information
Investor FAQ
Share Buyback
Agenda and Events
Reporting and Presentations
Corporate Governance
Ethics and Compliance
Investor Inquiries and Feedback
Sustainability
Sustainability
Environment
People and Society
Compliance and Integrity
Responsible Sourcing
Global Quality
Careers
Careers
Welcome to Lonza
Life at Lonza
Employee Benefits
Early Career Opportunities
Inclusion, Diversity and Belonging
Join Our Talent Community
Contact
Search
Cancel
Visp Site Leadership Team
Home
Visp, Switzerland
Visp Leadership Team
Meet the Visp Site Leadership Team
Renzo Cicillini
Site Head Visp
Fabian Wyer
Specialized Modalities: Head of Microbial Operations Visp
Martin Wellhöfer
Integrated Biologics: Head of Operations Mammalian
Gerhard Braun
Advanced Synthesis: Head of Small Molecules Development Services and Small/Mid-Scale Operations
Franz Stucky
Head of Infrastructure & Services
Gerhard Helmerich
Head of Supply Chain
Martin Witschard
Head of Environment, Health & Safety
Claudio Cescato
Head of Quality
Xavier Poch
Delivery Lead Bio | Visp, Global Engineering
Giovanni Gallo
Head of Human Resources
Mathias Forny
Head of Site Communications
Andreas Glauninger
Head of Finance, Shared Infrastructure
Corinna Bachmann
Head of Site Development & Support Services
Cookie Settings
|
Terms and Conditions
|
Legal Disclaimer
|
Privacy Policy
|
Accessibility
|
Sitemap